Skip to content Skip to footer

International Cannabis Weekly: 325

November 17, 2023

Highlights

Share this story
Highlights

‘DIFFICULTY IN THE DETAILS’ SEES GERMANY’S CANNABIS ACT DELAYED

Germany’s landmark Cannabis Act (CanG), which would establish an adult-use cannabis framework in Europe’s most populous country, has been pushed back by a number of months.

READ MORE  »

UKRAINE LAWMAKERS POISED TO PASS MEDICAL CANNABIS LEGALISATION BILL

READ MORE »

MARYLAND OPENS FIRST CANNABIS BUSINESS LICENCE APPLICATIONS

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
New Report

Highlights

Share this story
Canada
  • Aurora Cannabis reports double-digit revenue growth and record pre-tax profits in Q2 as EU medical cannabis sales soar.
  • Canopy Growth announces financial results for Q2 2024, showing third consecutive quarter of revenue growth.
  • Toronto’s Avicanna reports Q3 revenue of C$6.27 million, a 90% increase from the previous quarter.
  • Allied Corp. successfully completes another shipment of medical cannabis from Colombia to Australia.
  • Toronto’s MediPharm Labs Corp. reports higher Q3 gross margin and moves closer to profitability.
  • British Columbia’s IM Cannabis Corp. reports Q3 earnings with C$12.37 million in sales.

Highlights

Share this story
Upcoming Event

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.